ATE260113T1 - Teriparatidhaltige stabilisierte lösungen - Google Patents

Teriparatidhaltige stabilisierte lösungen

Info

Publication number: ATE260113T1
Authority: AT; Austria
Prior art keywords: solutions containing; stabilized solutions; containing teriparatide; teriparatide; stabilized
Prior art date: 1997-12-09

Application number

AT98123225T

Other languages

English (en)

Inventor

Chin-Ming Chang

Henry A Havel

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-09

Filing date

1998-12-07

Publication date

2004-03-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22086574&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE260113(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-12-07 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2004-03-15 Application granted granted Critical

2004-03-15 Publication of ATE260113T1 publication Critical patent/ATE260113T1/de

Links

108010049264 Teriparatide Proteins 0.000 title 1
OGBMKVWORPGQRR-UMXFMPSGSA-N teriparatide Chemical compound C([C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)[C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CNC=N1 OGBMKVWORPGQRR-UMXFMPSGSA-N 0.000 title 1
229960005460 teriparatide Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
General Chemical & Material Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Organic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Dermatology (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Silver Salt Photography Or Processing Solution Therefor (AREA)

AT98123225T 1997-12-09 1998-12-07 Teriparatidhaltige stabilisierte lösungen ATE260113T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US6907597P	1997-12-09	1997-12-09

Publications (1)

Publication Number	Publication Date
ATE260113T1 true ATE260113T1 (de)	2004-03-15

Family

ID=22086574

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT98123225T ATE260113T1 (de)	1997-12-09	1998-12-07	Teriparatidhaltige stabilisierte lösungen

Country Status (31)

Country	Link
EP (2)	EP1417972B2 (de)
JP (1)	JP4405666B2 (de)
KR (1)	KR100482703B1 (de)
CN (1)	CN1198644C (de)
AR (1)	AR018526A1 (de)
AT (1)	ATE260113T1 (de)
AU (1)	AU759726B2 (de)
BR (1)	BR9813463A (de)
CA (1)	CA2314313C (de)
CY (1)	CY1114000T1 (de)
CZ (1)	CZ302401B6 (de)
DE (1)	DE69821872T2 (de)
DK (2)	DK1417972T4 (de)
EA (1)	EA004761B1 (de)
EG (1)	EG23675A (de)
ES (2)	ES2405994T5 (de)
HU (1)	HU230784B1 (de)
ID (1)	ID27741A (de)
IL (1)	IL136662A (de)
MY (1)	MY120063A (de)
NO (1)	NO327302B1 (de)
NZ (1)	NZ505222A (de)
PE (1)	PE20000001A1 (de)
PL (1)	PL194268B1 (de)
PT (2)	PT1417972E (de)
SK (1)	SK288203B6 (de)
TR (1)	TR200002134T2 (de)
TW (1)	TW570811B (de)
UA (1)	UA72884C2 (de)
WO (1)	WO1999029337A1 (de)
ZA (1)	ZA9811127B (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL140984A0 (en) *	1998-07-23	2002-02-10	Lilly Co Eli	Fsh and fsh variant formulations, products and methods
US20030166525A1 (en)	1998-07-23	2003-09-04	Hoffmann James Arthur	FSH Formulation
DZ2873A1 (fr)	1998-08-19	2003-12-15	Lilly Co Eli	Procédé pour augmenter la dureté et la rigidité osseuse.
US7022674B2 (en)	1999-12-16	2006-04-04	Eli Lilly And Company	Polypeptide compositions with improved stability
US20020061838A1 (en) *	2000-05-17	2002-05-23	Barton Holmquist	Peptide pharmaceutical formulations
IL147731A0 (en) *	2000-05-19	2002-08-14	Bionebraska Inc	Peptide pharmaceutical formulations
NZ523457A (en) *	2000-06-30	2004-11-26	Daiichi Suntory Pharma Co	Composition for stimulating bone formation comprising hPTH in which the acetic acid component is low enough for administration to the nasal mucosa
JP5052736B2 (ja) *	2001-05-30	2012-10-17	中外製薬株式会社	タンパク質製剤
EP1767213A3 (de) *	2001-11-05	2007-04-25	Eli Lilly & Company	Verfahren zur Verbesserung der Stabilität eines knochenverbindenen Implantats
EP1444263A4 (de) *	2001-11-05	2005-04-20	Lilly Co Eli	Verfahren zur verbesserung der stabilität eines knochenverbindenden implantats
US8088734B2 (en)	2003-01-21	2012-01-03	Unigene Laboratories Inc.	Oral delivery of peptides
DK1610822T4 (en)	2003-04-02	2019-01-14	Ares Trading Sa	Liquid pharmaceutical FSH and LH formulations together with a nonionic surfactant
EP1638595B1 (de)	2003-06-20	2013-03-20	Ares Trading S.A.	Gefriergetrocknete fsh / lh formulierungen
CN1838968A (zh)	2003-08-08	2006-09-27	艾伯吉尼斯公司	针对甲状旁腺激素(pth)之抗体和其用途
US7318925B2 (en)	2003-08-08	2008-01-15	Amgen Fremont, Inc.	Methods of use for antibodies against parathyroid hormone
US7329725B1 (en)	2003-10-29	2008-02-12	Nastech Pharmaceutical Company Inc.	Phage displayed Trp cage ligands
DK3300721T4 (da)	2003-11-20	2025-03-03	Novo Nordisk As	Propylenglycol-holdige peptidformuleringer hvilke er optimale til fremstilling og til anvendelse i injektionsindretninger
AU2004309395C1 (en)	2003-12-23	2012-10-04	Infinity Discovery, Inc.	Analogs of benzoquinone-containing ansamycins for the treatment of cancer
US20060046962A1 (en)	2004-08-25	2006-03-02	Aegis Therapeutics Llc	Absorption enhancers for drug administration
US9895444B2 (en)	2004-08-25	2018-02-20	Aegis Therapeutics, Llc	Compositions for drug administration
US20140162965A1 (en)	2004-08-25	2014-06-12	Aegis Therapeutics, Inc.	Compositions for oral drug administration
US8642564B2 (en)	2004-08-25	2014-02-04	Aegis Therapeutics, Llc	Compositions for drug administration
US8268791B2 (en)	2004-08-25	2012-09-18	Aegis Therapeutics, Llc.	Alkylglycoside compositions for drug administration
US9114069B2 (en)	2004-08-25	2015-08-25	Aegis Therapeutics, Llc	Antibacterial compositions for drug administration
WO2006025882A2 (en) *	2004-08-25	2006-03-09	The Uab Research Foundation	Absorption enhancers for drug administration
KR100700869B1 (ko) *	2005-06-03	2007-03-29	재단법인 목암생명공학연구소	Ｐｔｈ, 완충제 및 안정제를 포함하는 안정한 ｐｔｈ조성물
CA2628945A1 (en)	2005-11-10	2007-05-24	Board Of Control Of Michigan Technological University	Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US8226949B2 (en)	2006-06-23	2012-07-24	Aegis Therapeutics Llc	Stabilizing alkylglycoside compositions and methods thereof
US7803770B2 (en)	2006-10-03	2010-09-28	Radius Health, Inc.	Method of treating osteoporosis comprising administration of PTHrP analog
BRPI0719821B8 (pt)	2006-10-03	2021-05-25	Ipsen Pharma Sas	composição estável na armazenagem apropriada para administração a pacientes
USRE49444E1 (en)	2006-10-03	2023-03-07	Radius Health, Inc.	Method of treating osteoporosis comprising administration of PTHrP analog
EP1958618A1 (de) *	2007-02-15	2008-08-20	Octapharma AG	Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
WO2008128063A1 (en) *	2007-04-12	2008-10-23	Infinity Discovery, Inc.	Hydroquinone ansamycin formulations
WO2008150929A1 (en) *	2007-05-29	2008-12-11	Manhattan Pharmaceuticals, Inc.	Topical compositions comprising a macromolecule and methods of using same
EP2170268A2 (de)	2007-06-25	2010-04-07	Amgen, Inc.	Zusammensetzungen von spezifischen bindungsmitteln für den hepatozyten-wachstumsfaktor
US20090258865A1 (en)	2008-03-28	2009-10-15	Hale Biopharma Ventures, Llc	Administration of benzodiazepine compositions
KR20110090925A (ko)	2008-10-15	2011-08-10	인피니티 파마슈티컬스, 인코포레이티드	안사마이신 하이드로퀴논 조성물
US8440631B2 (en)	2008-12-22	2013-05-14	Aegis Therapeutics, Llc	Compositions for drug administration
KR20190095552A (ko) *	2009-09-09	2019-08-14	아사히 가세이 파마 가부시키가이샤	1회당 100∼200 단위의 ｐｔｈ가 주 1회 투여되는 것을 특징으로 하는, ｐｔｈ 함유 골다공증 치료/예방제
BR112012013725A2 (pt)	2009-12-07	2017-01-10	Univ Michigan Tech	paratormônio de urso preto e métodos de usar o paratormônio de uso preto.
ES2683902T3 (es)	2011-06-14	2018-09-28	Hale Biopharma Ventures, Llc	Administración de benzodiacepina
CN102731643A (zh) *	2012-06-26	2012-10-17	深圳翰宇药业股份有限公司	一种治疗骨质疏松多肽的制备方法
CN103301058A (zh) *	2013-06-17	2013-09-18	深圳翰宇药业股份有限公司	一种特立帕肽注射用组合物及其制备方法和制剂
KR20250152679A (ko)	2015-04-29	2025-10-23	래디어스 파마슈티컬스, 인코포레이티드	암을 치료하는 방법
CN106309358A (zh) *	2015-06-29	2017-01-11	成都金凯生物技术有限公司	含有人甲状旁腺激素的药物组合物及其制备方法与用途
JP6634758B2 (ja) *	2015-09-25	2020-01-22	ニプロ株式会社	液体組成物及び凍結乾燥製剤
MY208384A (en)	2016-03-01	2025-05-05	Ascendis Pharma Bone Diseases As	Pth prodrugs
US12453778B2 (en)	2016-09-29	2025-10-28	Ascendis Pharma Bone Diseases A/S	Incremental dose finding in controlled-release PTH compounds
KR102627405B1 (ko)	2016-09-29	2024-01-18	아센디스 파마 본 디지즈 에이/에스	조절 방출 pth 화합물을 위한 투여 용법
HRP20230383T1 (hr)	2016-09-29	2023-07-07	Ascendis Pharma Bone Diseases A/S	Pth spojevi s malim omjerima maksimalne prema minimalnoj koncentraciji
JP7481115B2 (ja)	2017-01-05	2024-05-10	ラジウスファーマシューティカルズ，インコーポレイテッド	Ｒａｄ１９０１－２ｈｃｌの多形性形態
US10996208B2 (en)	2017-04-28	2021-05-04	Radius Health, Inc.	Abaloparatide formulations and methods of testing, storing, modifying, and using same
KR102665710B1 (ko)	2017-08-24	2024-05-14	노보 노르디스크 에이/에스	Glp-1 조성물 및 그 용도
US20200289621A1 (en) *	2017-09-22	2020-09-17	Asahi Kasei Pharma Corporation	Teriparatide-containing liquid pharmaceutical composition having excellent stability
CA3075984C (en) *	2017-09-22	2024-10-01	Asahi Kasei Pharma Corporation	LIQUID PHARMACEUTICAL COMPOSITION CONTAINING TERIPARATIDE WITH EXCELLENT PHARMACOKINETIC AND/OR SAFETY PROPERTIES
JP2019060866A (ja) *	2017-09-22	2019-04-18	旭化成ファーマ株式会社	液状医薬組成物の体内動態を予測する方法
CN108159404B (zh) *	2018-01-05	2019-08-27	北京博康健基因科技有限公司	重组人甲状旁腺激素制剂及其制备方法
WO2019220654A1 (ja) *	2018-05-17	2019-11-21	旭化成ファーマ株式会社	Ｎ－ホルミルピぺリジン含有量が低減されている、及び／又は、凍結乾燥ケーキの崩潰又は収縮が抑制されている、製剤
MY209748A (en) *	2019-02-11	2025-07-31	Ascendis Pharma Bone Diseases As	Liquid pharmaceutical formulations of pth conjugates
CN112439054B (zh) *	2019-08-28	2023-05-16	深圳翰宇药业股份有限公司	一种特立帕肽缓释凝胶注射液及其制备方法
JP7761567B2 (ja)	2020-02-18	2025-10-28	ノヴォノルディスクアー／エス	医薬製剤
EP4110370A4 (de) *	2020-03-30	2023-06-07	Sichuan Luzhou Buchang Bio-Pharmaceutical Co., Ltd.	Formulierungen des humanen parathyroidhormons (pth) und verfahren zur herstellung davon
JP2024521399A (ja)	2021-06-10	2024-05-31	ニューレリス、インク．	小児患者における発作性障害を治療するための組成物および方法
CN113967249A (zh) *	2021-12-10	2022-01-25	深圳先进技术研究院	甲状旁腺激素在制备治疗男性抑郁症的药物或保健品中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS6360940A (ja) *	1986-09-01	1988-03-17	Toyo Jozo Co Ltd	白内障の予防または治療剤
JP2505812B2 (ja) *	1987-07-10	1996-06-12	旭化成工業株式会社	ｈ―ＰＴＨ（１―３４）凍結乾燥組成物
US5059587A (en) *	1987-08-03	1991-10-22	Toyo Jozo Company, Ltd.	Physiologically active peptide composition for nasal administration
DE3935738A1 (de) *	1989-10-27	1991-05-08	Forssmann Wolf Georg	Arzneimittel, enthaltend das humane parathormon-fragment (1-37) als aktiven wirkstoff
GB9020544D0 (en) *	1990-09-20	1990-10-31	Sandoz Ltd	Improvements in or relating to organic compounds
ES2129048T3 (es) *	1991-12-09	1999-06-01	Asahi Chemical Ind	Composicion estabilizada de hormona paratiroide.
EP0679088B1 (de)	1992-09-29	2002-07-10	Inhale Therapeutic Systems	Pulmonale abgabe von aktiven fragmenten des parathormons
IT1255723B (it) †	1992-10-09	1995-11-13		Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
US5496801A (en) *	1993-12-23	1996-03-05	Allelix Biopharmaceuticals Inc.	Parathyroid hormone formulation
DE19538687A1 (de) †	1995-10-17	1997-04-24	Boehringer Mannheim Gmbh	Stabile pharmazeutische Darreichungsformen enthaltend Parathormon

1998
- 1998-12-04 ZA ZA9811127A patent/ZA9811127B/xx unknown
- 1998-12-04 MY MYPI98005507A patent/MY120063A/en unknown
- 1998-12-07 AT AT98123225T patent/ATE260113T1/de not_active IP Right Cessation
- 1998-12-07 ES ES03104219T patent/ES2405994T5/es not_active Expired - Lifetime
- 1998-12-07 AR ARP980106213A patent/AR018526A1/es active IP Right Grant
- 1998-12-07 EG EG151498A patent/EG23675A/xx active
- 1998-12-07 PT PT3104219T patent/PT1417972E/pt unknown
- 1998-12-07 DK DK03104219.5T patent/DK1417972T4/en active
- 1998-12-07 DK DK98123225T patent/DK0920873T3/da active
- 1998-12-07 PT PT98123225T patent/PT920873E/pt unknown
- 1998-12-07 EP EP03104219.5A patent/EP1417972B2/de not_active Expired - Lifetime
- 1998-12-07 DE DE69821872T patent/DE69821872T2/de not_active Revoked
- 1998-12-07 EP EP98123225A patent/EP0920873B1/de not_active Revoked
- 1998-12-07 ES ES98123225T patent/ES2215268T3/es not_active Expired - Lifetime
- 1998-12-08 KR KR10-2000-7006211A patent/KR100482703B1/ko not_active Expired - Lifetime
- 1998-12-08 NZ NZ505222A patent/NZ505222A/en not_active IP Right Cessation
- 1998-12-08 CA CA002314313A patent/CA2314313C/en not_active Expired - Lifetime
- 1998-12-08 SK SK1532-2000A patent/SK288203B6/sk not_active IP Right Cessation
- 1998-12-08 ID IDW20001318A patent/ID27741A/id unknown
- 1998-12-08 CZ CZ20002115A patent/CZ302401B6/cs not_active IP Right Cessation
- 1998-12-08 PL PL98340902A patent/PL194268B1/pl unknown
- 1998-12-08 IL IL13666298A patent/IL136662A/en not_active IP Right Cessation
- 1998-12-08 HU HU0004447A patent/HU230784B1/hu unknown
- 1998-12-08 UA UA2000074034A patent/UA72884C2/uk unknown
- 1998-12-08 TR TR2000/02134T patent/TR200002134T2/xx unknown
- 1998-12-08 BR BR9813463-9A patent/BR9813463A/pt not_active Application Discontinuation
- 1998-12-08 EA EA200000629A patent/EA004761B1/ru not_active IP Right Cessation
- 1998-12-08 AU AU17177/99A patent/AU759726B2/en not_active Expired
- 1998-12-08 CN CNB988119641A patent/CN1198644C/zh not_active Ceased
- 1998-12-08 JP JP2000524006A patent/JP4405666B2/ja not_active Expired - Lifetime
- 1998-12-08 WO PCT/US1998/026043 patent/WO1999029337A1/en not_active Ceased
- 1998-12-09 TW TW087120429A patent/TW570811B/zh not_active IP Right Cessation
- 1998-12-09 PE PE1998001200A patent/PE20000001A1/es not_active IP Right Cessation
2000
- 2000-06-08 NO NO20002945A patent/NO327302B1/no not_active IP Right Cessation
2013
- 2013-05-17 CY CY20131100405T patent/CY1114000T1/el unknown

Also Published As

Publication number	Publication date
CZ20002115A3 (en)	2001-05-16
EP0920873A2 (de)	1999-06-09
DK1417972T3 (da)	2013-05-13
HUP0004447A2 (hu)	2001-04-28
CZ302401B6 (cs)	2011-05-04
NO20002945L (no)	2000-07-07
NZ505222A (en)	2003-05-30
TR200002134T2 (tr)	2000-11-21
JP4405666B2 (ja)	2010-01-27
BR9813463A (pt)	2000-10-10
EA004761B1 (ru)	2004-08-26
EA200000629A1 (ru)	2000-12-25
ES2405994T5 (es)	2019-01-30
CN1281370A (zh)	2001-01-24
IL136662A (en)	2004-09-27
HK1021798A1 (en)	2000-07-07
EP0920873B1 (de)	2004-02-25
PT920873E (pt)	2004-06-30
MY120063A (en)	2005-08-30
IL136662A0 (en)	2001-06-14
ES2215268T3 (es)	2004-10-01
KR100482703B1 (ko)	2005-04-14
ID27741A (id)	2001-04-26
PL340902A1 (en)	2001-03-12
EG23675A (en)	2007-04-15
DE69821872T2 (de)	2005-01-05
TW570811B (en)	2004-01-11
UA72884C2 (uk)	2005-05-16
EP1417972B1 (de)	2013-04-10
EP0920873A3 (de)	1999-08-04
CA2314313A1 (en)	1999-06-17
SK288203B6 (sk)	2014-07-02
KR20010032881A (ko)	2001-04-25
PE20000001A1 (es)	2000-01-17
PT1417972E (pt)	2013-05-24
AU1717799A (en)	2005-05-16
AU759726B2 (en)	2003-04-17
JP2001525372A (ja)	2001-12-11
HUP0004447A3 (en)	2003-06-30
DE69821872D1 (de)	2004-04-01
EP1417972A1 (de)	2004-05-12
DK1417972T4 (en)	2018-10-22
SK15322000A3 (sk)	2001-05-10
PL194268B1 (pl)	2007-05-31
CY1114000T1 (el)	2016-07-27
DK0920873T3 (da)	2004-06-28
ZA9811127B (en)	2000-07-11
NO327302B1 (no)	2009-06-02
CA2314313C (en)	2005-02-08
HU230784B1 (en)	2018-05-02
CN1198644C (zh)	2005-04-27
ES2405994T3 (es)	2013-06-04
EP1417972B2 (de)	2018-08-22
NO20002945D0 (no)	2000-06-08
WO1999029337A1 (en)	1999-06-17
AR018526A1 (es)	2001-11-28

Legal Events

Date

Code

Title

Description

2004-09-15

UEP

Publication of translation of european patent specification

Ref document number: 0920873

Country of ref document: EP

2008-10-15

RZN

Patent revoked

Publication	Publication Date	Title
ATE260113T1 (de)	2004-03-15	Teriparatidhaltige stabilisierte lösungen
DE69839157D1 (de)	2008-04-03	Fullurene enthaltendes katherdersystem
DE69826749D1 (de)	2004-11-11	Stabilisierte Persäurelösungen
NO20003131D0 (no)	2000-06-16	Krystallinsk teriparatid
NO2006014I1 (no)	2006-11-13	Insulin glulisin
ID24430A (id)	2000-07-20	Turunan-turunan benzamidina
ID24529A (id)	2000-07-20	Turunan-turunan 9-oksima eritromisin
PT1034144E (pt)	2002-07-31	Vidro protegido
ATE255409T1 (de)	2003-12-15	Cisplatinhaltige mikrogranulate
DE69815673D1 (de)	2003-07-24	Stabilisierte hydroxylaminlösungen
NO983733L (no)	1999-02-15	Ryggsekk
NO981003D0 (no)	1998-03-06	Zirkoniumoksydholdige katalysatorer
ID20897A (id)	1999-03-25	Susunan penutup-rapat
FI974068A0 (fi)	1997-10-27	Anordning foer faestande av tillaeggsutrustning i bil
FI972138A0 (fi)	1997-05-20	Returtraog i bestrykningsanordning
ID21138A (id)	1999-04-29	Teknologi film-tipis untuk head-drum
DE69813735D1 (de)	2003-05-28	Druckkopfsystem
FI974242A0 (fi)	1997-11-14	Formframstaellning av plywoodprofil i kontinuerlig drift
BR7700789U (pt)	1998-12-22	Prumo
FI974114A0 (fi)	1997-11-03	Skorstenshatt (regntak)
NO976014D0 (no)	1997-12-19	Bæresystem for ryggsekker
DE69804527D1 (de)	2002-05-08	Flaschenkasten
KR970060407U (ko)	1997-12-10	운반구
IT243063Y1 (it)	2002-02-28	Fissaggio per ombrellone
FI3092U1 (fi)	1997-10-13	Lompakko matkapuhelinkotelo